Drug Screening Market Making CAGR of 12.50% During 2018 to 2025 and Forecasting Organizations Like Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories Inc. (U.S), Biomedical Diagnostics (Belgium), CannAmm (Cannada), MPD, Inc. (U.S.), Danaher (U.S.),

The Global Drug Screening Market accounted to USD 5.7 billion in 2016 growing at a CAGR of 12.50% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Visit: http://databridgemarketresearch.com/reports/global-drug-screening-market

Also the Global Drug Screening Market By Products and Services (Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents), Sample Type (Urine, Breath, Saliva, Hair, Blood, Skin, Sweat)Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024.

Drug screening is used for detecting prescribed as well as illegal drugs in blood, urine, and other biological samples basically at hospitals, places of employment, trained athletes, schools and post-accident. It is considered as a basic part of ongoing diagnosis and treatment, can be by purpose or random. Drug screening takes place at the time of some suspicious cause, generally before employment or sports event. Few of the illegal drugs are cocaine, heroin, amphetamine and cannabis along with which new psychoactive substances (NPS), for instance , ketamine, phenethylamines, and piperazine are rising in the drug market.

Get Free Sample Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-drug-screening-market&utm_source=O-Pi

Major market drivers and restraints:

• Rising awareness on drug screening policy
• Increasing misuse and consumption of drugs and alcohol
• Addition of drug addicts
• Increasing disposable income
• Growing trend of today’s generation
• Violation of rights related to drug testing in some regions

Global Drug Screening Market Segmentation:

On the basis of products and services, global drug screening market is segmented into immunoassay analyzers, chromatography, breath analyzers, rapid testing devices, assay kits and reagents.

On the basis of sample type, global drug screening market is segmented into urine, breath, saliva, hair, blood, skin, sweat. Due to the low cost and reliability urine sample is the most commonly found sample.

On the basis of geography, global drug screening market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Speak to Research Analyst for Further Query: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-drug-screening-market&utm_source=O-Pi


Global Drug Screening Market Competitive Analysis:
The global drug screening market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes global drug screening market shares for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors:

Some of the major players operating in global drug screening market are Siemens Healthcare GmbH (Germany), Quest Diagnostics Incorporated (U.S.), Alere (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Abbott (U.S.),Hoffmann -La Roche Ltd(Switzerland), BioMerieux SA (France), Express Diagnostics Int’l, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories Inc. (U.S), Biomedical Diagnostics (Belgium), CannAmm (Cannada), MPD, Inc. (U.S.), Danaher (U.S.), Synergy Health plc.(U.K), Agilent Technologies (U.S),and Shimadzu Corporation (Japan) among others.

Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-drug-screening-market&utm_source=O-Pi

About Us
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com

This release was published on openPR.